| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 09/02/2009 | EP0995448B1 Compound for diagnosing malignant tumors |
| 09/02/2009 | CN101519658A Construction and expression of vector of tumstatin T7 of tumstatin T7 peptide and derivative T7-NGR thereof |
| 09/02/2009 | CN101519655A Abalone HINT gene and protein and application of same for preparing anticarcinogenic drug |
| 09/02/2009 | CN101519646A CIK cell, as well as preparation method and cell preparation thereof |
| 09/02/2009 | CN101519438A Cyclic peptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519437A Cyclic heptapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519436A Cyclic octapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519435A Cyclic nonapeptide compound in Hsisha sponge and application thereof |
| 09/02/2009 | CN101519424A Acanthopanaxgenin acid with antitumor and antiangiogenic activities |
| 09/02/2009 | CN101519423A Betulinic acid analogue and preparation method and application thereof |
| 09/02/2009 | CN101519410A Preparation method for metallic thiophene ring ternary complex with anti-cancer activity and application thereof |
| 09/02/2009 | CN101519404A 15-cyclothiaketone derivative, preparation method and application thereof |
| 09/02/2009 | CN101519394A 3-aryl-coumarin derivatives and preparation method and application thereof |
| 09/02/2009 | CN101519393A Novel method for preparing Scopoletin |
| 09/02/2009 | CN101519385A Small molecule compound being capable of promoting proliferation of stem cells and function thereof |
| 09/02/2009 | CN101519378A Diaryl pyrimidyl guanidine and preparation method and pharmaceutical use of same |
| 09/02/2009 | CN101518655A Application of human interleukin-24 gene recombined vector mediated by adenovirus in preparing tumor analgesic medicament |
| 09/02/2009 | CN101518653A Methods of treatment using anti-erbb antibody-maytansinoid conjugates |
| 09/02/2009 | CN101518651A Pastille slow-release material and preparation method and application thereof |
| 09/02/2009 | CN101518648A Soluble receptor BR43x2 and methods of using |
| 09/02/2009 | CN101518647A Human papilloma virus preventative vaccine, construction method and application |
| 09/02/2009 | CN101518644A Application of Ang-2 and genes thereof in pharmacy |
| 09/02/2009 | CN101518640A Chinese traditional medicine prescription for treating tumor |
| 09/02/2009 | CN101518633A Traditional Chinese medicine for treating thyroid cancer |
| 09/02/2009 | CN101518611A Traditional Chinese medicine for treating bone tumor |
| 09/02/2009 | CN101518610A Orthopedic persistent ailment treating medicament and preparation method thereof |
| 09/02/2009 | CN101518607A Traditional Chinese medicine for treating carcinoma of kidney |
| 09/02/2009 | CN101518594A Anti-tumor immunity-enhancing traditional Chinese medicine preparation and preparation method thereof |
| 09/02/2009 | CN101518593A Traditional Chinese medicine composition for curing hyperplasia of mammary glands and resisting tumors and preparation method thereof |
| 09/02/2009 | CN101518587A Traditional Chinese medicine for treating laryngeal carcinoma |
| 09/02/2009 | CN101518586A Medicament for treating cancer caused by dry heat |
| 09/02/2009 | CN101518563A Non-oral preparation of pachyrhizua angulatus total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518562A Non-oral preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518561A Oral medicinal preparation of kudzuvine root total aglycon, preparation method and application thereof |
| 09/02/2009 | CN101518556A Polysaccharide with antitumor and immunologic adjuvant function as well as preparation method and purpose thereof |
| 09/02/2009 | CN101518553A Oral medicinal preparation of ginkgo leaf total flavonoid aglycone, preparation method and an application thereof |
| 09/02/2009 | CN101518551A Ganoderma spore oil fat emulsion and quality control method and application thereof |
| 09/02/2009 | CN101518546A Application of combination of cadmium chloride and zinc chloride in preparation of anti-tumor drugs |
| 09/02/2009 | CN101518545A Synthesis and surface decorating method of rare-earth nanometer compound material |
| 09/02/2009 | CN101518538A Application of tanshinone compound used as specific inhibitor for CYP1 family |
| 09/02/2009 | CN101518528A Application of carbocyanine dye near infrared fluorescent compound |
| 09/02/2009 | CN101518525A Preparation method for semi-pinnated brake herb extract injection |
| 09/02/2009 | CN100535013C Selective targeting of tumor vasculature using antibody molecules |
| 09/02/2009 | CN100534991C Heterocyclic inhibitors of ERK 2 and uses thereof |
| 09/02/2009 | CN100534988C 2-arylimino-2,3-dihydrothiazole derivatives, methods for preparing them and therapeutic use thereof |
| 09/02/2009 | CN100534981C 2-propylidene-19-nor-vitamin d compounds |
| 09/02/2009 | CN100534529C Ordered molecular presentation of antigens, method of preparation and use |
| 09/01/2009 | USRE40901 14- Beta -hydroxy-1,14-carbonate-baccatine III and V derivatives, 13-substituted by an isoserine residue; remarkable cytotoxic and anticarcinogenic-agent activities; capable of overcoming the resistance of cell lines expressing the multidrug resistant phenotype; breast, ovarian, colon cancers |
| 09/01/2009 | US7582778 Podophyllotoxin |
| 09/01/2009 | US7582762 Salt and crystalline forms of (2R)-anti-5-{3-[4-(10,11-difluoromethanodibenzosuber-5-YL)piperazin-1-YL]-2-hydroxypropoxy}quinoline |
| 09/01/2009 | US7582756 3-(4-amidopyrrol-2-ylmethylidene)-2-indolinone derivatives as protein kinase inhibitors |
| 09/01/2009 | US7582734 natural ligand for the orphan G-Protein Coupled Receptor (GPCR) ChemerinR and uses thereof in diagnosis and immuno therapy of a disease; monoclonal antibody; chemiattractant proteins; useful for the diagnosis and treatment of a disease or disorder related to the dysregulation of GPCR signaling |
| 09/01/2009 | US7582669 Aminoindazole derivatives as medicaments and pharmaceutical compositions including them |
| 09/01/2009 | US7582666 Substituted 2-oxo-3-phenyl-5-carbonylaminomethyl-1,3-oxazolines and their use as anticoagulant and antithrombotics |
| 09/01/2009 | US7582660 2-thio-substituted imidazole derivatives and their use in pharmaceutics |
| 09/01/2009 | US7582645 Pyrimidine derivatives for treatment of hyperproliferative disorders |
| 09/01/2009 | US7582644 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 09/01/2009 | US7582642 4-{9-Isopropyl-6-[(pyridin-3-ylmethyl)-amino]-9H-purin-2-ylamino}-2-methyl-hexan-3-ol;antiproliferative agents; viricides; alopecia; strokes; central nervous system diorders; neurodegenerative diseases; antidiabetic agents; mitosis; cyclin dependent kinase inhibitors; protein kinase inhibitors |
| 09/01/2009 | US7582640 3-[[5-Ethyl-6-[4-(1,2,3,4-tetrahydro-1,8-naphthyridin-7-yl)-1-piperidinyl]-4-pyrimidinyl]amino]-N-[(phenylmethoxy)carbonyl]alanine; osteoporois; restenosis; arteriosclerosis; cell adhesion/bone bioresorption inhibiters; cardiovascular disorders; antitumor agents; anticarcinogenic agents; bone disorders |
| 09/01/2009 | US7582628 Pyrrolo[3,4-c]pyrazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 09/01/2009 | US7582614 Use of myxoma virus for the therapeutic treatment of cancer and chronic viral infection |
| 09/01/2009 | US7582613 Adjuvant compositions and methods for enhancing immune responses to polynucleotide-based vaccines |
| 09/01/2009 | US7582603 Treatment of gastrointestinal inflammation by administering a peptide antagonist of tight junction opening that binds to the zonula occludens receptor, yet does not physiologically modulate the opening of mammalian tight junctions; celiac disease, inflammatory bowel disease |
| 09/01/2009 | US7582448 nucleotide sequences coding protein of urogenital system for identifying modulators for treatment of cell proliferative and metastatic disorders |
| 09/01/2009 | US7582440 Imaging, diagnosis and treatment of disease |
| 09/01/2009 | US7582439 Detecting the presence/absence of a complex of a Bim molecule (a novel member of the Bcl-2 family) and an antibody specific for a specific amino acid sequence;modulating physiological cell death or survival and/or modulating cell cycle entry; antiapoptosis; anticarcinogenic agents; autoimmune diseases |
| 09/01/2009 | US7582437 Adaptor protein that binds to mammalian toll-like receptor 3, and gene thereof |
| 09/01/2009 | US7582317 Food supplements comprising, as a health component, sargahydroquinoic acid or derivative thereof |
| 09/01/2009 | US7582313 Methods of organ regeneration using Hox 11-expressing pluripotent cells |
| 09/01/2009 | US7582289 administering to proliferating cells in a mammal having a Ras-activated pathway a viruse selected from modified adenovirus, modified HSV, modified vaccinia virus and modified parapoxvirus virus under conditions which result in lysis of neoplasmic cell |
| 09/01/2009 | US7582288 Methods of targeting multiple cytokines |
| 09/01/2009 | US7582287 Method for treating cervical cancer |
| 09/01/2009 | CA2570329C Liposome preparation containing slightly water-soluble camptothecin |
| 09/01/2009 | CA2432428C Quinazoline derivatives, pharmaceutical compositions containing these compounds, their use and processes for preparing them |
| 09/01/2009 | CA2389411C Use of egfr tyrosine kinase inhibitor for preventing breast cancer |
| 09/01/2009 | CA2283536C Compositions and methods for elimination of unwanted cells |
| 09/01/2009 | CA2274469C Serum-derived factor inducing cell differentiation and medical uses thereof |
| 08/27/2009 | WO2009105712A1 Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 08/27/2009 | WO2009105673A2 Tumor therapy with replication competent sindbis viral vectors |
| 08/27/2009 | WO2009105671A2 Methods and compositions related to peptides and proteins with c-terminal elements cross-reference to related applications |
| 08/27/2009 | WO2009105513A2 Novel compounds and methods for therapy |
| 08/27/2009 | WO2009105430A1 Treating cancer with desthiazolyl ritonavir |
| 08/27/2009 | WO2009105269A1 Antibodies directed to angiopoietin-1 and angiopoietin-2 and use thereof |
| 08/27/2009 | WO2009105257A1 Compounds for treating proliferative disorders |
| 08/27/2009 | WO2009105238A2 Kinase protein binding inhibitors |
| 08/27/2009 | WO2009105230A2 Methods for treating cancer using combination therapy |
| 08/27/2009 | WO2009104911A2 Uses as agents for prophylaxis or treatment of cervical cancer |
| 08/27/2009 | WO2009104802A1 Novel aminopyridine derivatives having aurora a selective inhibitory action |
| 08/27/2009 | WO2009104696A1 Oral or enteral composition useful for recovery of physical functions |
| 08/27/2009 | WO2009104198A2 Metal conjugates of indole 3- aldehyde azine and its derivatives and uses thereof |
| 08/27/2009 | WO2009104167A1 A substance or composition for the treatment of cancer |
| 08/27/2009 | WO2009104152A1 Combination treatment for ovarian cancer |
| 08/27/2009 | WO2009104150A1 Combination comprising bosentan for treating ovarian cancer |
| 08/27/2009 | WO2009104149A1 Combination comprising paclitaxel for treating ovarian cancer |
| 08/27/2009 | WO2009104100A2 Antibody combinations, and methods of making and using same |
| 08/27/2009 | WO2009104027A1 Therapeutic application of triciclic aromatic and saturated benzo(4,5)thieno-(2,3-d)pyrimidine derivates, as well as their therapeutically acceptable salts |
| 08/27/2009 | WO2009104026A1 Tricyclic benzo[4,5]thieno-[2,3-d]pyrimidine-4-yl-amin derivatives, their salts, process for producing the compounds and their pharmaceutical use |
| 08/27/2009 | WO2009104019A1 Combination therapy 238 |
| 08/27/2009 | WO2009103969A1 Synthetic scfv analogue to the 6313/g2 (anti angiotensin ii type 1 receptor) monoclonal antibody variable regions |
| 08/27/2009 | WO2009103807A1 Copper organocomplexes, use thereof as antitumor means and for protecting healthy tissue from ionizing radiation |